CVRx, Inc. (CVRX) Insider Ownership

Historic Insider Ownership Trends

As of April 22, 2026, CVRx's top three insider holders are Johnson Johnson (TenPercentOwner, 4.04Mn shares), Partners 10 L P Nea (TenPercentOwner, 2.20Mn shares), Enterprise Associates 10 L P New (TenPercentOwner, 2.03Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Johnson Johnson - 0 4,040,861 01 Dec, 2025
Partners 10 L P Nea - 0 2,199,471 07 Jul, 2021
Enterprise Associates 10 L P New - 2,026,083 0 07 Jul, 2021
Kirk G. Nielsen - 0 1,910,134 19 May, 2025
Geoffrey B Pardo - 0 1,829,022 02 Jul, 2021
Mudit K. Jain - 0 980,183 23 Feb, 2026
Mudit K. Jain - 0 933,383 02 Jul, 2021
Kevin Hykes Pres Ceo 284,237 0 03 Mar, 2026
Jared Oasheim Chief Financial Officer 96,703 0 03 Mar, 2026
Robert Allen John Chief Revenue Officer 86,036 0 03 Mar, 2026
Philip B. Adamson Chief Medical Officer 61,578 0 16 Mar, 2026
Paul Verrastro Chief Mktg Strat Officer 60,551 0 03 Mar, 2026
Dean Bruhn-Ding Vp Of Reg. Affairs And Qa 54,648 0 10 Feb, 2022
Gregory Morrison Chief Human Resources Officer 34,000 0 04 Mar, 2026
Brent Binkowski Chief Operating Officer 31,600 0 03 Mar, 2026
Joseph P Slattery - 30,645 0 15 Aug, 2024
John M Nehra - 28,266 100 02 Jul, 2021
Nadim Yared Chief Executive Officer 26,255 0 31 Jan, 2024
John Brintnall Chief Strategy Officer And Sec 21,901 0 26 Apr, 2022
Jared Oasheim Chief Financial Officer 9,585 0 06 Jun, 2022
Mudit K. Jain - 5,650 0 18 Feb, 2026
Craig E. Palmer Svp, U.S. Sales 1,229 0 27 Mar, 2024
Liz Galle Vp Of Global Clinical Research 778 0 18 Oct, 2023
Ali Behbahani - 316 0 18 Dec, 2023

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
27 Feb, 2026 Philip B. Adamson Common Stock A 41,000 $0.00 62,840 D A
02 Mar, 2026 Philip B. Adamson Common Stock D 1,262 $7.90 61,578 D S
27 Feb, 2026 Philip B. Adamson Stock Option (right to buy) A 62,000 $0.00 62,000 D A
02 Mar, 2026 Gregory Morrison Common Stock A 34,000 $0.00 34,000 D A
02 Mar, 2026 Gregory Morrison Stock Option (right to buy) A 154,500 $0.00 154,500 D A
27 Feb, 2026 Jared Oasheim Common Stock A 61,000 $0.00 98,447 D A
27 Feb, 2026 Robert Allen John Common Stock A 35,000 $0.00 90,000 D A
27 Feb, 2026 Kevin Hykes Common Stock A 159,000 $0.00 292,000 D A
27 Feb, 2026 Brent Binkowski Common Stock A 15,000 $0.00 31,600 D A
27 Feb, 2026 Paul Verrastro Common Stock A 45,000 $0.00 61,835 D A
02 Mar, 2026 Kevin Hykes Common Stock D 7,763 $7.90 284,237 D S
27 Feb, 2026 Brent Binkowski Stock Option (right to buy) A 23,000 $0.00 23,000 D A
02 Mar, 2026 Paul Verrastro Common Stock D 1,284 $7.90 60,551 D S
02 Mar, 2026 Jared Oasheim Common Stock D 1,744 $7.90 96,703 D S
02 Mar, 2026 Robert Allen John Common Stock D 3,964 $7.90 86,036 D S
27 Feb, 2026 Robert Allen John Stock Option (right to buy) A 52,000 $0.00 52,000 D A
27 Feb, 2026 Paul Verrastro Stock Option (right to buy) A 67,000 $0.00 67,000 D A
27 Feb, 2026 Kevin Hykes Stock Option (right to buy) A 238,000 $0.00 238,000 D A
27 Feb, 2026 Jared Oasheim Stock Option (right to buy) A 91,000 $0.00 91,000 D A
20 Feb, 2026 Mudit K. Jain Common Stock A 46,800 $6.36 980,183 I P